BOMAN; Erik
Patent Applications and Registrations
Patent applications and USPTO patent grants for BOMAN; Erik.The latest application filed is for "tumor position determination".
- BOMAN; Erik - Uppsala SE
- Boman; Erik - Chula Vista CA
- Boman, Erik - Bonita CA
| Patent | Date |
|---|---|
| Tumor Position Determination App 20220071577 - BOMAN; Erik | 2022-03-10 |
| Cytokine inhibitors Grant 7,919,617 - Boman , et al. April 5, 2 | 2011-04-05 |
| Cytokine inhibitors Grant 7,897,599 - Boman , et al. March 1, 2 | 2011-03-01 |
| Alpha-ketoamides And Derivatives Thereof App 20100273797 - Boman; Erik ; et al. | 2010-10-28 |
| Alpha-ketoamides and derivatives thereof Grant 7,749,999 - Boman , et al. July 6, 2 | 2010-07-06 |
| Cytokine Inhibitors App 20100093735 - Boman; Erik ; et al. | 2010-04-15 |
| Cytokine Inhibitors App 20100093734 - Boman; Erik ; et al. | 2010-04-15 |
| Cytokine inhibitors App 20050107399 - Boman, Erik ; et al. | 2005-05-19 |
| Compounds for the treatment of HIV infection App 20040248850 - Ernst, Justin T. ; et al. | 2004-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 